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In March 2002, typhus fever was diagnosed in two
patients residing in West Virginia and Georgia. Both
patients were hospitalized with severe febrile illnesses, and
both had been recently exposed to or had physical contact
with flying squirrels or flying squirrel nests. Laboratory
results indicated Rickettsia prowazekii infection. 
T
yphus fever from Rickettsia prowazekii infection is a
severe and occasionally fatal disease in humans.
Frequently referred to as epidemic typhus or louse-borne
typhus, this disease can cause large epidemics when con-
ditions are favorable for person-to-person spread of body
lice (Pediculus humanus humanus). For the last few
decades, reported outbreaks have been confined mainly to
the cold mountainous regions of Africa and South America
and have disproportionately affected impoverished and
displaced communities (1). 
Infections with R. prowazekii are rarely described in the
United States. From 1976 to 2001, a total of 39 human R.
prowazekii infections were documented in persons with no
reported contact with body lice or persons with lice (2–5).
Nearly all of these cases were in the eastern United States,
and in approximately one third of cases, contact with fly-
ing squirrels (Glaucomys spp.) or with flying squirrel nests
occurred before disease onset.
Flying squirrels are the only known vertebrate reservoir
of  R. prowazekii, other than humans, and contact with
these animals has been linked to most sporadic typhus
cases in the United States. Interest in this disease was high
in the 10 years after the first isolation of R. prowazekii
from flying squirrels (6,7), but few cases have been report-
ed since 1985. We describe two cases of flying
squirrel–associated typhus that occurred in West Virginia
and Georgia in 2002 and provide a contemporary summa-
ry of this disease in the United States.
Case Reports
West Virginia
During February 2002, a 44-year-old man in West
Virginia arrived in the emergency department, with
headache, fever, and chills. The patient also had hematuria,
joint pain, discomfort on the left side of his abdomen, and
vomiting. Laboratory findings included elevated levels of
alanine transaminase (ALT) and aspartate transaminase
(AST) (100 and 91 U/L, respectively), leukocyte count of
4.1 x 109/L, platelet count of 249 x 109/L, and erythrocyte
sedimentation rate of 42 mm/h. The patient also had diver-
ticulosis. Atreatment regimen of levofloxacin and metron-
idazole was begun, and the patient was admitted to the
hospital. The condition worsened, and an infectious dis-
ease specialist was consulted on day 4 of hospitalization.
At this time, the patient was febrile (maximum tempera-
ture, 38°C), reported myalgia and malaise, and had mildly
injected sclerae (without photophobia). AST and ALT lev-
els remained slightly elevated. Levofloxacin and metron-
idazole were discontinued. Because the patient was a
recreational hunter, serologic tests for Rocky Mountain
spotted fever, ehrlichiosis, adenovirus, Lyme disease, and
cytomegalovirus (CMV) were ordered, and doxycycline
was given as empiric therapy. Serologic tests were nega-
tive for all agents. The patient was discharged on day 7 of
hospitalization with a diagnosis of immunoglobulin (Ig) A
nephropathy and hepatitis. At a follow-up visit (day 27
after illness onset), the patient still had myalgias, fatigue,
and conjunctivitis, although his fever and abdominal pain
had resolved. At this time, serologic testing for typhus
group rickettsiae showed reactive IgM antibodies at a titer
of 512 and IgG at a titer of <64. An additional serum sam-
ple obtained on day 53 after illness onset was tested at the
Centers for Disease Control and Prevention (CDC) by
indirect-immunofluorescence assay (IFA) and showed
titers of IgM and IgG antibodies reactive with R.
prowazekii of 128 and 1,024, respectively, indicating a
recent acute infection.
During January, the patient had spent several nights in
a hunting cabin in a rural area of Hardy County, West
Virginia. Flying squirrels had infested the cabin every win-
ter for several years; evidence of nesting materials and
rodent feces in the attic and wall spaces was visible. The
patient did not report seeing flying squirrels during visits
to the cabin in 2002 but reported having removed rodent
nesting materials and debris from a wall space 10–15 days
before becoming ill.
Georgia
During March 2002, a 57-year-old man from Fulton
County, Georgia, received medical treatment for confusion
associated with a febrile illness of approximately 1-week
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myalgia, headache, vomiting, anorexia, and cyclic fever.
During medical evaluation, dehydration, atrial fibrillation,
and abnormal results for liver enzyme tests were also
found. Pronounced neurologic symptoms with expressive
aphasia, impaired coordination, and confusion were
demonstrated. The cerebrospinal fluid (CSF) sample had
normal protein and glucose levels, was negative for bacte-
ria by routine culture, and was negative for herpes simplex
virus by polymerase chain reaction (PCR). Cefepime,
ampicillin, and gentamicin were given, and a presumptive
diagnosis of bacterial meningitis was made. Additional his-
tory was obtained from the patient’s wife, who reported that
2 weeks before onset of symptoms, the patient had removed
a flying squirrel carcass from the air intake chamber of the
furnace in his office building’s basement. He had also taken
the furnace filter outside and brushed it vigorously to
remove dust and animal hair that had collected over the
winter. The infectious disease specialist prescribed doxycy-
cline for treatment of suspected flying squirrel–associated
typhus after a history of contact with these animals was
established. The patient reported no history of having had a
similar unexplained illness in the past and reported no con-
tact with human body lice or with persons with lice. 
Serum specimens obtained on days 7, 13, and 23 after
illness onset were evaluated at CDC for antibodies reactive
with R. prowazekii antigens. The titer of specific IgG anti-
bodies was 8,192 for all three specimens. The patient was
discharged from the hospital on day 9 and demonstrated
normal mental status by day 10 of discharge. 
Serum samples were collected from the eight people
who also worked in the patient’s office building. These
specimens were screened by IFA for presence of antibody
(IgG) reactive with typhus group rickettsiae antigens. All
were negative (titer <16).
Cases from 1985 to 2002
A review of records at CDC identified two additional
cases of flying squirrel–associated typhus during 1985 to
2002 (Table). Typhus is not a nationally notifiable disease
in the United States, and public health officials become
aware of cases only when specialized confirmatory labora-
tory assays, performed at state health departments or CDC,
are requested. 
Conclusions
Inhalation and transdermal or mucous membrane inoc-
ulation of infected louse feces are well-established routes
of pathogen transmission during epidemics of human
louse-borne typhus. The mechanism by which R.
prowazekii is transmitted from flying squirrels to humans
is less well understood. Various routes have been hypothe-
sized, but none have been empirically established.
Plausible mechanisms include inhalation or direct intro-
duction (through mucous membrane or dermal abrasion)
of infected feces from louse or flea ectoparasites of flying
squirrels or through the bite of infected flea ectoparasites
of flying squirrels (9). At least one species of flea ectopar-
asite (Orchopeas howardii) of flying squirrels is known to
opportunistically bite humans and could serve as a bridge
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Table. Epidemiologic and clinical characteristics of flying squirrel–associated typhus fever in the United States, 1984–2002
a 
Case no. 
Characteristic  I  II
b  III  IV 
Sex  Male  Female  Male  Male 
Age (y)  54  54  44  57 
State of residence  Massachusetts  North Carolina  West Virginia  Georgia 
Mo of onset  February 1998  September 1999  January 2002  March 2002 
Flying squirrel contact  Y  Y  Y  Y 
Serologic titer (no. onset)         
8,192 (7)  4,096 (10) 
8,192 (13) 
IgG Rickettsia prowazekii 
32,768 (38)  nd  128 (53)  8,192 (23) 
4,096 (7) 
4,096 (13) 
IgG R. typhi  nd  nd  <32 (53) 
4,096 (23) 
IgM R. prowazekii  nd  2,048 (18)  1,024 (53)  nd 
IgM R. typhi  nd  512 (18)  1,024 (53)  nd 
Symptoms         
Max fever (°C)   nr  40°C  38°C  40°C 
Chills  Y  nr  Y  Y 
Headache  Y  Y  Y  Y 
Rash (type, location)  nr  Y (macular, trunk)  N  Y
c 
aIg, immunoglobulin; Y, yes; N, no; nd, not done; nr, not recorded. 
bRecurrent illness, first episode January 1999, flying squirrel contact, rash at that time. Other symptoms associated with both episodes. Serologic titer from second 
episode. 
cRash herpetic, not directly attributable to R. prowazekii infection but commonly seen in context of classic louse-borne epidemic typhus (8). vector for transmission from flying squirrel to human.
Rickettsiae transmission among captive flying squirrels,
however, has only been demonstrated with a louse vector
(9,10). While the exact mechanism of pathogen transmis-
sion has not yet been determined, the lack of detectable
exposure to R. prowazekii in the household members or co-
workers of documented cases (3,5) supports the idea that
the risk for R. prowazekii infection after casual or indirect
exposure to flying squirrels is low. Rather, existing evi-
dence suggests that infection follows from close physical
contact with flying squirrels or from exposure to a concen-
trated source of infectious materials (e.g., nests, dander, or
infected ectoparasites). 
Currently, no formal system for epidemic typhus sur-
veillance exists in the United States, and diagnosis is hin-
dered by the lack of rapid and reliable commercial tests. R.
prowazekii infections can be confirmed by serologic test-
ing, PCR, or organism culture. Commercial testing is,
however, not widely available, and commercial serologic
tests lack specificity because most detect antibodies reac-
tive with a surrogate typhus-group rickettsial antigen (typ-
ically R. typhi). PCR (in conjunction with DNA sequenc-
ing) is a highly specific diagnostic tool (11) but has low
sensitivity for commonly available clinical specimens,
such as whole blood or serum. PCR may be used to greater
effect on other clinical specimens (e.g., cerebrospinal
fluid, lymphocytes, and skin biopsy) if they are collected
and submitted for testing. Specific serologic and molecular
testing is available at CDC for specimens submitted
through state public health laboratories.
Sporadic epidemic typhus occurs in the United States,
primarily during winter and spring, and in regions within
the normal range of the southern flying squirrel
(Glaucomys volans) (12). This illness can be severe, result-
ing in protracted hospital stays, particularly when diagno-
sis and appropriate treatment are delayed. In these two
cases, treatment with tetracycline antibiotics was initiated
after other broad-spectrum antibiotics were used. When
therapy was changed to the appropriate antibiotic, the
response was rapid. Tetracycline antibiotics are highly
effective therapies for typhus (13). These cases underscore
the importance of obtaining a thorough history of animal
and arthropod contact in patients with acute febrile illness.
Physicians and healthcare providers should remain alert to
the signs and symptoms of epidemic typhus and be aware
of appropriate diagnostic methods and antibiotic treat-
ments (13,14).
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